IP Library Granted Patent US 9,206,399
Granted Patent B2
US 9,206,399 · App. 11/666,786 · Granted Dec 8, 2015

Immunogenic bacterial vesicles with outer membrane proteins

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,206,399
App. No.
11/666,786
Granted
Dec 8, 2015
Kind
B2
Abstract

Knockout of the meningococcal mltA homolog gives bacteria that spontaneously release vesicles that are rich in immunogenic outer membrane proteins and that can elicit cross-protective antibody responses with higher bactericidal titres than OMVs prepared by normal production processes. Thus the invention provides a bacterium having a knockout mutation of its mltA gene. The invention also provides a bacterium, wherein the bacterium: (i) has a cell wall that includes peptidoglycan; and (ii) does not express a protein having the lytic transglycosylase activity of MltA protein. The invention also provides compositions comprising vesicles that, during culture of bacteria of the invention, are released into the culture medium.

Claims (3)

1. A Neisseria bacterium, wherein: (i) the bacterium has a knockout mutation of its mItA gene; and (ii) the bacterium has a knockout mutation of its siaA gene.

2. The bacterium of claim 1 , which is N. meningitidis.

3. The bacterium of claim 2 , wherein the N. meningitidis is from serogroup A, B, C, W135 or Y.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2016
From: NOVARTIS AG
To: GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 037800/0287 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2008
From: NOVARTIS VACCINES AND DIAGNOSTICS SRL
To: NOVARTIS AG
Reel/Frame 021615/0451 →